Literature DB >> 27180317

Multicomponent, multitarget integrated adjustment - Metabolomics study of Qizhiweitong particles curing gastrointestinal motility disorders in mice induced by atropine.

Xin Chang1, Shuai Wang2, Yong-Rui Bao2, Tian-Jiao Li2, Xiao-Meng Yu3, Xian-Sheng Meng4.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Qizhiweitong particles (QZWT) which is derived from the Sinisan decoction in Shang Han Za Bing Lun, composed of Bupleurum chinenis, Paeonia obovata, Citrus aurantium L., Glycyrrhiza uralensis Fisch., Cyperus rotundus and Rhizoma Corydalis is a traditional Chinese medicine (TCM) treating gastrointestinal diseases. It have been used in clinical for years. It have been used in clinical for years. According to previous research, Bupleurum chinenis, Citrus aurantium, Cyperus rotundus in QZWT play the role of promoting gastric peristalsis, which consist of complex chemical constituents. The aim of this study is to probe the multiple effective components with gastrointestinal prokinetic efficacy in QZWT and investigate the multitarget integrated adjustment mechanism of QZWT curing atropine-induced gastrointestinal motility dysfunction mice.
MATERIALS AND METHODS: One hundred and thirty two male mice were randomly divided into 11 groups, including control group, model group, Domperidone group, Mosapride group, QZWT group and six components groups. With gastric retention rate, rate of small intestine propulsion, serum content of GAS and MTL as indexes to evaluate the curing effect on gastrointestinal movement disorders caused by atropine in mice. A serum metabonomics method based on the ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS) had been established to investigate the mechanism of QZWT and these components, and PCA and PLS-DA have been used to distinguish different groups and found potential biomarkers.
RESULTS: Four components from six present good prokinetic effects, including Bupleurum Polysaccharide, Citrus aurantium flavonoid, Citrus aurantium essential oil and Cyperus rotundus flavonoids. These components and QZWT regulate 5 potential biomarkers in the body, and primarily involved in 5 metabolic pathways. These potential biomarkers possess direct or indirect connections, each biomarker regulated by multiple components, each component adjusting multiple targets, and QZWT is nearly the sum of its components.
CONCLUSIONS: This experiment deepened our understanding of insufficient gastrointestinal dynamics, confirmed that QZWT treating gastrointestinal disorders was through multicomponent, multitarget ways. These results fully reflect the multiple targets synergy characteristics of TCM.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  25-Hydroxycholecalciferol; 5,6-Indolequinone-2-carboxylic acid; 5-HT; Acetylcholine; Gastrointestinal motility disorders; Glyceric acid; Glycerophosphocholine; Levodopa; Metabolomics; Multicomponent; Multitarget; Phospholipid; Prostaglandin E(2); Qizhiweitong particles; Tryptophan

Mesh:

Substances:

Year:  2016        PMID: 27180317     DOI: 10.1016/j.jep.2016.05.024

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  4 in total

1.  A Randomized, Double-Blind, Multicenter, Placebo-Controlled Trial of Qi-Zhi-Wei-Tong Granules on Postprandial Distress Syndrome-Predominant Functional Dyspepsia.

Authors:  Qing Su; Sheng-Liang Chen; Hua-Hong Wang; Lie-Xin Liang; Ning Dai; Bin Lyu; Jun Zhang; Rong-Quan Wang; Ya-Li Zhang; Yue Yu; Jin-Song Liu; Xiao-Hua Hou
Journal:  Chin Med J (Engl)       Date:  2018-07-05       Impact factor: 2.628

2.  The Key Ingredient Acacetin in Weishu Decoction Alleviates Gastrointestinal Motility Disorder Based on Network Pharmacology Analysis.

Authors:  Xuan Guo; Yin Xu; Hua-Liang Tan; Xiao-Juan Wang; Lin Xiao
Journal:  Mediators Inflamm       Date:  2021-09-21       Impact factor: 4.711

3.  Clinical study on post evaluation after listing of Qizhi Weitong granules: Study protocol clinical trial (SPIRIT compliant).

Authors:  Lin Xu; Jiaqi Zhang; Juanjuan Li; Lin Lv; Zedan Zhang; Fengyun Wang; Xudong Tang
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

4.  Efficacy of Chinese Herbal Formula Sini Zuojin Decoction in Treating Gastroesophageal Reflux Disease: Clinical Evidence and Potential Mechanisms.

Authors:  Shaowei Li; Mengfen Huang; Guojing Wu; Weihan Huang; Zhanhui Huang; Xiaoqian Yang; Jinming Ou; Qipeng Wei; Chengli Liu; Shaoyuan Yu
Journal:  Front Pharmacol       Date:  2020-02-27       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.